スポンサーの機会 - サイトライン・ファーマインテリジェンス・アワード・ジャパン2023

CMICはCurrent Medical Information Centerを表します。1992年、中村和男博士が日本初のCROとしてシミックを設立しました。現在、日本最大の臨床CROであり、医薬品開発、臨床試験および臨床試験実施施設の管理、臨床から商業ベースのGMP製造、薬事コンサルティング、販売＆マーケティングソリューションなど包括的なサービスを提供しています。製薬会社、バイオテクノロジー企業、医療機器企業が日本市場に参入する際や、アジアでの臨床試験を実施する際、あるいは日米間での医薬品開発・製造ニーズの橋渡しをする際にサポートいたします。シミックグループは7,000名以上の従業員を擁し、25の拠点をグローバルに展開しています。

ICON plc is a world-leading healthcare intelligence and clinical research organisation, with over 38,000 employees in 93 locations in 46 countries around the world, headquartered in Dublin. We advance clinical research by providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Our services span the entire lifecycle of product development, from molecule to medicine, across a broad range of therapeutic areas. We develop new innovations, drive emerging therapies forward, and improve patient lives.

Avance Clinical is a premium full-service Contract Research Organisation (CRO) based in Australia, New Zealand and North America, providing high-quality clinical research services to the international drug development industry which brings innovative new drugs to patients. Avance Clinical has more than 260 staff and has backing from the private equity group, Riverside Company, to support global expansion plans.

Avance Clinical offers clinical project management, trial monitoring, regulatory support, safety reporting, scientific and medical writing, data management, statistical and pharmacokinetic services, and external clinical auditing. We operate to the highest standards of compliance required by global regulatory agencies such as the FDA to ensure acceptance of data for drug approvals.

Our clients are international biotech companies in their early phases of drug development that require fast, agile, and adaptive solution-oriented clinical research services. The company uses state-of-the-art technology, gold standard systems, and deep scientific expertise to provide clients with the most successful outcomes.

The Avance Clinical team offers exceptional study approval and success rates which can be attributed to its deep scientific expertise, advanced data technologies, knowledge of the Australian, New Zealand and North American regulatory environment, and its extensive relationships with sites and KOLs.